STOCK MARKET BSE NSE

Remdesivir to be used in patients with moderate to severe COVID: Health ministry

It also warned against use of the drug in patients who are not on oxygen support or in home settings.

Published: 24th December 2021 09:29 PM  |   Last Updated: 24th December 2021 09:29 PM   |  A+A-

Remdesivir

Remdesivir (Photo | PTI)

By PTI

NEW DELHI: The Centre on Friday said Remdesivir drug should only be used in patients with 'moderate to severe' COVID-19 and those with no renal or hepatic dysfunction within 10 days of the onset of any symptom.

It also warned against use of the drug in patients who are not on oxygen support or in home settings.

According to the clinical guidance issued by the Union health ministry for management of the infection in adult patients, Remdesivir has been asked to be "used in patients with moderate to severe COVID-19 and those with no renal or hepatic dysfunction within 10 days of onset of any symptom".

The Tocilizumab drug may be considered for use in the presence of severe disease (preferably within 24 to 48 hours of onset of severe disease/ICU admission), according to the guidelines.

Tocilizumab can be used in case of significantly raised inflammatory markers (CRP &/or IL-6), condition not improving despite use of steroids and no active bacterial/fungal/tubercular infection.

The ministry also said that those above 60 years of age, with cardiovascular disease, hypertension, diabetes and other immunocompromised states are at high risk for severe disease and mortality.

According to the guidelines, coronavirus patients have been classified into those affected by mild, moderate and severe disease.

For mild disease, home isolation and care is recommended, while admission in a ward is recommended for those battling moderate disease and ICU has been recommended for patients with severe COVID-19, they added.



Comments(1)

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

  • Remdesivir

    Game started
    24 days ago reply
flipboard facebook twitter whatsapp